Identification of fused 16β,17β-oxazinone-estradiol derivatives as a new family of non-estrogenic 17β-hydroxysteroid dehydrogenase type 1 inhibitors
摘要:
A new family of cyclic carbamate-estradiol derivatives has been designed to remove the intrinsic estrogenic activity of a parent acyclic compound reported as a potent inhibitor of 17 beta-hydroxysteroid dehydrogenase type 1 (17 beta-HSD1). The synthesis of two series of fused 16 beta,17 beta-oxazinone-estradiol derivatives, saturated compounds 7a-d and unsaturated compounds 10a-d, led to the identification of 10b, a 17 beta-HSD1 inhibitor (IC50 = 1.4 mu M) without estrogenic activity in estrogen-sensitive T-47D cells. Interestingly, this compound was found selective over 17 beta-HSD2 and 17 beta-HSD12. A computational analysis of inhibitors into 17 beta-HSD1 by molecular docking also revealed interesting structure activity relationships that could be helpful in the design of new generation of 16 beta,17 beta-oxazinone-estradiol analogs. (C) 2015 Elsevier Masson SAS. All rights reserved.
A new family of cyclic carbamate-estradiol derivatives has been designed to remove the intrinsic estrogenic activity of a parent acyclic compound reported as a potent inhibitor of 17 beta-hydroxysteroid dehydrogenase type 1 (17 beta-HSD1). The synthesis of two series of fused 16 beta,17 beta-oxazinone-estradiol derivatives, saturated compounds 7a-d and unsaturated compounds 10a-d, led to the identification of 10b, a 17 beta-HSD1 inhibitor (IC50 = 1.4 mu M) without estrogenic activity in estrogen-sensitive T-47D cells. Interestingly, this compound was found selective over 17 beta-HSD2 and 17 beta-HSD12. A computational analysis of inhibitors into 17 beta-HSD1 by molecular docking also revealed interesting structure activity relationships that could be helpful in the design of new generation of 16 beta,17 beta-oxazinone-estradiol analogs. (C) 2015 Elsevier Masson SAS. All rights reserved.